25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial.
Lorigan, Paul C
AffiliationDepartment of Oncology, University of Oxford, CB2 0QQ, Oxford
MetadataShow full item record
AbstractStudies evaluating a relationship of vitamin D in patients with primary melanoma have consistently identified an inverse correlation with Breslow thickness, but an inconsistent impact on survival. Vitamin D in later stages of melanoma has been less studied.
Citation25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial. 2018, Br J Cancer
JournalBritish Journal of Cancer